Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza A (H1N1) 2009 Monovalent Subunit Vaccine With and Without MF59 Adjuvant in Young Children
2014-005107-24Phase 3
- Sponsor
- Novartis
- Start
- Dec 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of monovalent H1N1 influenza virus subunit vaccine in influenza A(H1N1)2009 (H1N1) (4 arms), sponsored by Novartis. Primary endpoints: Antibody responses after first and second vaccinations and Superiority in GMT HI titer.
02
Drugs
monovalent H1N1 influenza virus subunit vaccine
03
Conditions
influenza A(H1N1)2009 (H1N1)
Beyond the preview
Go deeper on 2014-005107-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005107-24.